NOVAVAX INC (NVAX) Earnings History & Surprises
NASDAQ:NVAX • US6700024010
10.44 USD
-0.36 (-3.33%)
Last: Mar 12, 2026, 02:08 PM
Past quarterly earnings results for NOVAVAX INC (NVAX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMay 6, 2026
PeriodQ1 / 2026
EPS Estimate-$0.24
Revenue Estimate77.142M
Last Reported
Release DateJan 12, 2026
PeriodQ4 / 2025
EPS Reported$0.11
EPS Surprise 122.14%
Revenue Surprise 59.82%
Beat Rate
56%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.11 | -0.50 | 122.14% | 113.25% | 147.139M | 92.064M | 59.82% | 66.61% |
| Q3 2025 | -1.25 | -1.21 | -3.30% | -64.47% | 70.445M | 42.976M | 63.92% | -16.64% |
| Q2 2025 | 0.62 | -0.09 | 827.96% | -37.37% | 239.24M | 150.92M | 58.52% | -42.42% |
| Q1 2025 | 2.93 | 0.72 | 306.88% | 379.05% | 666.655M | 350.73M | 90.08% | 610.30% |
| Q4 2024 | -0.83 | -0.52 | -58.31% | 42.36% | 88.311M | 86.068M | 2.61% | -69.69% |
| Q3 2024 | -0.76 | -0.81 | 5.92% | 39.68% | 84.512M | 75.235M | 12.33% | -54.80% |
| Q2 2024 | 0.99 | 1.67 | -40.73% | 70.69% | 415.484M | 467.75M | -11.17% | -2.11% |
| Q1 2024 | -1.05 | -1.09 | 3.25% | 69.21% | 93.855M | 103.18M | -9.04% | 15.94% |
| Q4 2023 | -1.44 | -0.46 | -214.89% | 36.84% | 291.342M | 328.41M | -11.29% | -18.48% |
| Q3 2023 | -1.26 | -1.87 | 32.56% | 41.40% | 186.986M | 161.71M | 15.63% | -74.55% |
| Q2 2023 | 0.58 | -1.41 | 141.01% | 108.88% | 424.426M | 243.94M | 73.99% | 128.31% |
| Q1 2023 | -3.41 | -3.53 | 3.43% | -233.20% | 80.951M | 89.364M | -9.41% | -88.50% |
| Q4 2022 | -2.28 | -0.94 | -142.97% | 79.61% | 357.4M | 390.81M | -8.55% | 60.85% |
| Q3 2022 | -2.15 | 1.60 | -234.40% | 50.12% | 734.6M | 597.97M | 22.85% | 310.85% |
| Q2 2022 | -6.53 | 5.61 | -216.36% | -37.47% | 185.9M | 1.037B | -82.07% | -37.62% |
| Q1 2022 | 2.56 | 2.75 | -6.76% | 183.93% | 704M | 862.11M | -18.34% | 57.42% |
| Q4 2021 | -11.18 | -1.84 | -508.26% | -314.07% | 222.2M | 338.43M | -34.34% | -20.56% |
| Q3 2021 | -4.31 | -3.98 | -8.16% | -34.27% | 178.8M | 341.31M | -47.61% | 13.89% |
| Q2 2021 | -4.75 | -3.70 | -28.22% | -1,483.33% | 298M | 395.63M | -24.68% | 739.44% |
| Q1 2021 | -3.05 | -3.67 | 16.89% | -425.86% | 447.2M | 238.58M | 87.44% | 13,052.94% |
| Q4 2020 | -2.70 | -1.52 | -77.46% | - | 279.7M | 310.98M | -10.06% | - |
| Q3 2020 | -3.21 | 1.77 | -281.70% | - | 157M | 235.17M | -33.24% | - |
| Q2 2020 | -0.30 | -0.43 | 29.64% | - | 35.5M | 40.371M | -12.07% | - |
| Q1 2020 | -0.58 | -0.80 | 27.56% | - | 3.4M | 1.778M | 91.23% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
268.30%
Max EPS beat (4)
827.96%
Min EPS beat (4)
-58.31%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
53.78%
Max Revenue beat (4)
90.08%
Min Revenue beat (4)
2.61%
Analysis
In the last 4 quarters, NVAX has beaten EPS estimates in 2 out of 4 releases
NVAX has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, NVAX has beaten the EPS estimates by 268.3% on average.
In the last 4 quarters, NVAX has beaten the revenue estimates by 53.8% on average.
NOVAVAX INC / NVAX Earnings FAQ
Can you provide the last earnings date for NOVAVAX INC?
NOVAVAX INC (NVAX) last reported earnings on 1/12/2026.
Did NVAX stock beat earnings estimates in the most recent quarter?
NOVAVAX INC (NVAX) beat EPS estimates and beat revenue estimates in the most recent quarter.
How often does NOVAVAX INC (NVAX) beat earnings estimates?
In the last 4 quarters, NOVAVAX INC (NVAX) has beaten EPS estimates in 2 out of 4 releases.